Switch theme
Sign up to access all valuation multiples
Nexstim Oyj is medical technology company. The company has developed a non-invasive brain stimulation technology for navigated transcranial magnetic stimulation (nTMS) with 3D navigation providing accurate and personalized targeting of TMS to the specific area of the brain. The company earns revenue from Finland, Rest of Europe, North America and Other. The majority of revenue is earned in North America.
2000
40
LTM Revenue $13.1M
LTM EBITDA $2.3M
$65.6M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Nexstim has a last 12-month revenue (LTM) of $13.1M and a last 12-month EBITDA of $2.3M.
In the most recent fiscal year, Nexstim achieved revenue of $9.8M and an EBITDA of $0.5M.
Nexstim expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Nexstim valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $13.1M | XXX | $9.8M | XXX | XXX | XXX |
| Gross Profit | $13.1M | XXX | $9.4M | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 96% | XXX | XXX | XXX |
| EBITDA | $2.3M | XXX | $0.5M | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 5% | XXX | XXX | XXX |
| EBIT | $1.2M | XXX | -$0.6M | XXX | XXX | XXX |
| EBIT Margin | 9% | XXX | -6% | XXX | XXX | XXX |
| Net Profit | n/a | XXX | -$1.0M | XXX | XXX | XXX |
| Net Margin | n/a | XXX | -10% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $1.7M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Nexstim's stock price is EUR 8 (or $9).
Nexstim has current market cap of EUR 56.9M (or $63.9M), and EV of EUR 58.4M (or $65.6M).
See Nexstim trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $65.6M | $63.9M | XXX | XXX | XXX | XXX | $0.14 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Nexstim has market cap of $63.9M and EV of $65.6M.
Nexstim's trades at 6.7x EV/Revenue multiple, and 127.9x EV/EBITDA.
Equity research analysts estimate Nexstim's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Nexstim's P/E ratio is not available.
See valuation multiples for Nexstim and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $63.9M | XXX | $63.9M | XXX | XXX | XXX |
| EV (current) | $65.6M | XXX | $65.6M | XXX | XXX | XXX |
| EV/Revenue | 5.0x | XXX | 6.7x | XXX | XXX | XXX |
| EV/EBITDA | 29.1x | XXX | 127.9x | XXX | XXX | XXX |
| EV/EBIT | 52.8x | XXX | -109.0x | XXX | XXX | XXX |
| EV/Gross Profit | 5.0x | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -63.8x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 332.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialNexstim's last 12 month revenue growth is 45%
Nexstim's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.3M for the same period.
Nexstim's rule of 40 is 38% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Nexstim's rule of X is 129% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Nexstim and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 45% | XXX | 45% | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Growth | 137% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | 38% | XXX | 50% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 129% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 3% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 6% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 102% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Nexstim acquired XXX companies to date.
Last acquisition by Nexstim was XXXXXXXX, XXXXX XXXXX XXXXXX . Nexstim acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Nexstim founded? | Nexstim was founded in 2000. |
| Where is Nexstim headquartered? | Nexstim is headquartered in Finland. |
| How many employees does Nexstim have? | As of today, Nexstim has 40 employees. |
| Is Nexstim publicy listed? | Yes, Nexstim is a public company listed on HEL. |
| What is the stock symbol of Nexstim? | Nexstim trades under NXTMH ticker. |
| When did Nexstim go public? | Nexstim went public in 2014. |
| Who are competitors of Nexstim? | Similar companies to Nexstim include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Nexstim? | Nexstim's current market cap is $63.9M |
| What is the current revenue of Nexstim? | Nexstim's last 12 months revenue is $13.1M. |
| What is the current revenue growth of Nexstim? | Nexstim revenue growth (NTM/LTM) is 45%. |
| What is the current EV/Revenue multiple of Nexstim? | Current revenue multiple of Nexstim is 5.0x. |
| Is Nexstim profitable? | Yes, Nexstim is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Nexstim? | Nexstim's last 12 months EBITDA is $2.3M. |
| What is Nexstim's EBITDA margin? | Nexstim's last 12 months EBITDA margin is 17%. |
| What is the current EV/EBITDA multiple of Nexstim? | Current EBITDA multiple of Nexstim is 29.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
